Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

Willie Reed Biography and Net Worth

Director of Zoetis

Dr. Willie M. Reed has served as a member of our board since March 2014. He has been the Dean of the College of Veterinary Medicine at Purdue University since 2007. Dr. Reed has more than 30 years of experience in animal health and veterinary medicine, gained during his tenure at Purdue University and Michigan State University, and as a Diplomate of the American College of Veterinary Pathologists and Charter Diplomate of the American College of Poultry Veterinarians. Dr. Reed has served as President of the Association of American Veterinary Medical Colleges (AAVMC), president of the American Association of Veterinary Laboratory Diagnosticians (AAVLD), president of the American Association of Avian Pathologists (AAAP) and chair of the American Veterinary Medical Association Council on Research. He has served on a number of committees for the National Institutes of Health and the United States Department of Agriculture.

Dr. Reed earned a Doctor of Veterinary Medicine degree from Tuskegee University in 1978, and a Ph.D. in Veterinary Pathology from Purdue University in 1982.

What is Willie M. Reed's net worth?: The estimated net worth of Willie M. Reed is at least $1.12 million as of June 10th, 2022. Dr. Reed owns 6,782 shares of Zoetis stock worth more than $1,117,945 as of December 21st. This net worth evaluation does not reflect any other assets that Dr. Reed may own. Learn More about Willie M. Reed's net worth.
How do I contact Willie M. Reed?: The corporate mailing address for Dr. Reed and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected]. Learn More on Willie M. Reed's contact information.
Has Willie M. Reed been buying or selling shares of Zoetis?: Willie M. Reed has not been actively trading shares of Zoetis in the last ninety days. Most recently, Willie M. Reed sold 1,855 shares of the business's stock in a transaction on Friday, June 10th. The shares were sold at an average price of $162.31, for a transaction totalling $301,085.05. Following the completion of the sale, the director now directly owns 6,782 shares of the company's stock, valued at $1,100,786.42. Learn More on Willie M. Reed's trading history.
Who are Zoetis' active insiders?: Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO & Director), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.
Are insiders buying or selling shares of Zoetis?: In the last twelve months, insiders at the sold shares 4 times. They sold a total of 3,132 shares worth more than $547,983.01. The most recent insider tranaction occured on April, 18th when EVP Roxanne Lagano sold 923 shares worth more than $139,529.91. Insiders at Zoetis own 0.2% of the company. Learn More about insider trades at Zoetis.
Information on this page was last updated on 4/18/2024.

Willie M. Reed Insider Trading History at Zoetis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/10/2022	Sell	1,855	$162.31	$301,085.05	6,782
8/23/2021	Sell	1,450	$207.10	$300,295.00	5,964
8/13/2020	Sell	1,885	$159.07	$299,846.95	4,635
6/13/2019	Sell	1,900	$110.58	$210,102.00	2,816
11/30/2018	Sell	3,205	$93.74	$300,436.70	566

Willie M. Reed Buying and Selling Activity at Zoetis

Zoetis Company Overview

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Today's Range

Now: $164.84

$163.53

$166.39

50 Day Range

MA: $178.52

$163.52

$194.45

2 Week Range

Now: $164.84

$144.80

$200.53

Volume

6,184,068 shs

Average Volume

2,552,173 shs

Market Capitalization

$74.37 billion

P/E Ratio

30.99

Dividend Yield

1.03%

Beta

0.89

AI breakthrough about to upend industry

From Porter & Company | Ad

I urge you to watch it now.